An evaluation of antimicrobial treatment for Whipple's Disease. Tetracycline versus trimethoprim-sulfamethoxazole

Digestive Diseases and Sciences
G E Feurle, Thomas Marth

Abstract

Whipple's disease is a multisystemic disorder in which almost all organ systems can be invaded by rod-shaped bacteria. Without extended antimicrobial therapy, its course is lethal. Empirically, treatment consists of tetracyclines given for one to two years. Trimethoprim-sulfamethoxazole, a compound that crosses the blood-brain barrier, has been suggested as an alternative when patients were observed with progressive cerebral involvement. There has never been a formal evaluation of the selection of antibiotics for the treatment of Whipple's disease. In the present nonrandomized, partially retrospective study, we compared the result of two treatment regimens in 30 patients, all examined personally. Twenty-two patients were treated with tetracycline and eight patients with trimethoprim-sulfamethoxazole. In five patients, therapy with tetracycline was changed to another antimicrobial agent because of treatment failure or drug intolerance. The main treatment measure was disappearance of the clinical symptoms such as weight loss, arthritis, malabsorption, fever, edema, central nervous system manifestations, lymphadenopathy, and congestive heart failure. Drug intolerance requiring a change of medication was also considered a treatment...Continue Reading

References

Jul 1, 1975·Acta Medica Scandinavica·L ElsborgN O Jacobsen
Nov 1, 1976·Medicine·D L KnoxF E Pittman
Sep 1, 1977·Journal of Neurology, Neurosurgery, and Psychiatry·F C RomanulR K Rosales
Apr 19, 1979·The New England Journal of Medicine·G E FeurleR Waldherr
Oct 1, 1979·European Journal of Clinical Investigation·G E FeurleV Lenhard
Dec 1, 1979·Acta Neuropathologica·J M Powers, S E Rawe
May 1, 1978·The Journal of Antimicrobial Chemotherapy·R W Barling, J B Selkon
Jul 30, 1992·The New England Journal of Medicine·D A RelmanS Falkow
Jun 1, 1991·Journal of Clinical Gastroenterology·J C BaiL A Boerr
Feb 7, 1966·JAMA : the Journal of the American Medical Association·J M RuffinW M Roufail
Nov 19, 1966·Die Medizinische Welt·W SchmittG Beneke
May 1, 1980·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·L R LapointeR Beaudry
Apr 1, 1983·The Journal of Antimicrobial Chemotherapy·E E Wang, C G Prober

❮ Previous
Next ❯

Citations

Apr 22, 1999·Arthritis and Rheumatism·J D O'DuffyD H Persing
Oct 8, 1999·Arthritis and Rheumatism·I MarieH Courtois
May 25, 2007·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·S MennelC Müller
May 21, 2013·Zeitschrift für Rheumatologie·P StaschT Langenegger
Apr 5, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·V Moos, T Schneider
Mar 15, 2002·Current Allergy and Asthma Reports·T Marth
Jun 10, 2010·Current Gastroenterology Reports·Payam AfsharPhilip A Higginbottom
Jul 11, 2006·Current Infectious Disease Reports·Mara M Lugassy, Elan D Louis
Nov 5, 1997·Gastrointestinal Endoscopy·M A Marcial, M Villafaña
Jan 28, 2003·Lancet·Thomas Marth, Didier Raoult
Mar 11, 2000·Neuromuscular Disorders : NMD·T R HelliwellK P Walsh
Jun 6, 2003·Best Practice & Research. Clinical Rheumatology·J S Hill Gaston, Mark S Lillicrap
Dec 6, 2000·Journal of Gastroenterology and Hepatology·G GarasG M Forbes
Jan 5, 2007·The New England Journal of Medicine·Florence FenollarDidier Raoult
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Maiwald, D Relman
Jul 20, 2010·The Journal of Antimicrobial Chemotherapy·Jean-Christophe LagierDidier Raoult
Jan 1, 1997·Journal of Clinical Gastroenterology·D SchillingJ F Riemann
Feb 28, 2008·Current Opinion in Gastroenterology·Thomas Marth, Thomas Schneider
Mar 13, 2010·Southern Medical Journal·Christos St BasagiannisSpiros D Ladas
Feb 6, 2007·Applied and Environmental Microbiology·Maximilian Schöniger-HekeleChristian Müller
Jul 4, 2001·Clinical Microbiology Reviews·F Dutly, M Altwegg
Nov 7, 2000·Journal of Clinical Pathology·S A Misbah, N P Mapstone
Dec 21, 2012·Future Microbiology·Alpha Kabinet KeitaFlorence Fenollar
Mar 25, 2006·Alimentary Pharmacology & Therapeutics·M OlmosJ C Bai
Aug 6, 2015·The New England Journal of Medicine·Deepti DamarajuJ Mark FitzGerald
Apr 4, 2017·Infectious Disease Clinics of North America·John J Ross
Sep 28, 2000·The American Journal of Gastroenterology·M LévyJ C Delchier
Mar 17, 2017·Clinical Microbiology Reviews·Ruben A V DolmansJohannes G Kusters
Sep 10, 2003·Current Gastroenterology Reports·Florence Fenollar, Didier Raoult
Mar 25, 2018·Digestive Diseases and Sciences·Isabel A HujoelAlberto Rubio-Tapia
Jul 6, 2004·Arquivos de neuro-psiquiatria·Marcondes C FrançaBenito P Damasceno
Mar 10, 2006·Current Infectious Disease Reports·Klaus MönkemüllerPeter Malfertheiner
Nov 1, 1996·Clinical Neurology and Neurosurgery·W I VerhagenM M Schuurmans
Jun 27, 2000·Gastroenterology·S Banerjee, J T LaMont
Nov 22, 2005·Infectious Disease Clinics of North America·John J Ross

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.